Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Buprenorphine Naltrexone-P1 A-Cocaine [Phase 1]

View source ↗

Summary

A completed Phase 1 study evaluated a buprenorphine/naltrexone combination for cocaine-related disorders, sponsored by the National Institute on Drug Abuse (NID…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine/Naltrexone (buprenorphine and naltrexone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-related Disorders | Phase 1 | Status: COMPLETED